Reference
Adamczyk M, et al. risankizumab as an effective therapeutic option in severe psoriasis unsuccessfully treated with therapies involving anti-tnF-alpha and anti-iL-17. Przeglad Dermatologiczny 107: 385-392, No. 4, 2020. Available from: URL: http://doi.org/10.5114/dr.2020.99882
Rights and permissions
About this article
Cite this article
Multiple drugs. Reactions Weekly 1843, 268 (2021). https://doi.org/10.1007/s40278-021-91370-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-021-91370-9